AMORFIX SUSPENDS DEVELOPMENT OF THE VCJD BLOOD TEST DIAGNOSTIC PROGRAM

Amorfix Life Sciences Ltd has announced that it has decided to suspend all development of their vCJD diagnostic test. Amorfix was considered to have been the leader in the race to develop a blood test to diagnose vCJD. Following the failure of their test to identify the plasma from a UK vCJD patient as positive the company has decided to abandon work on this test.

31 MAY 2010